T

Transcenta

88 employees

Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Biopharma

Date founded

2019

Funding rounds raised

Total raised

$137M

from 21 investors over 21 rounds

T

Transcenta raised undisclosed on November 29, 2021

Investors: Lilly Asia Ventures, ARCH Venture Partners and Teng Yue Partners, L.P.

T

Transcenta raised $105M on December 23, 2020

Investors: 深圳市碧桂园创新投资有限公司, Lilly Asia Ventures, Teng Yue Partners, L.P., China Merchants Fund and Qatar Investment Authority

T

Transcenta raised $100M on January 8, 2020

Investors: Lilly Asia Ventures, Teng Yue Partners, L.P., Fortune Ventures, Sequoia Capital China, Temasek, Hillhouse Capital Management and China Merchants Capital

T

Transcenta raised $137M on January 2, 2019

Investors: Lilly Asia Ventures, Sequoia Capital China, Temasek, ARCH Venture Partners, 泰康集团 and Teng Yue Partners, L.P.

FAQ